000
| 01712cam 2200361za 4500 |
---|
001 | 9.856866 |
---|
003 | CaOODSP |
---|
005 | 20221107155631 |
---|
007 | cr ||||||||||| |
---|
008 | 180523s2018 onc o f000 0 eng d |
---|
020 | |a9780660266626 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH13-9/13-2018E-PDF |
---|
245 | 00|aGuidance document |h[electronic resource] : |bfees for the right to sell drugs. |
---|
246 | 30|aFees for the right to sell drugs |
---|
260 | |aOttawa : |bHealth Canada, |c2018. |
---|
300 | |a15 p. |
---|
500 | |aIssued also in French under title: Ligne directrice : frais à payer le droit de vendre une drogue. |
---|
500 | |aCover title. |
---|
500 | |a"Date adopted: 1998/05. Revised date: 2018/06/13. Effective date: 2018/06/13." |
---|
500 | |a"Publication date: June 2018." |
---|
500 | |aIssued also in HTML format. |
---|
520 | |a"This document provides guidance on the interpretation of the Fees in Respect of Drugs and Medical Devices Regulations (Fee Regulations) with a focus on how the Fees for the Right to Sell Drugs, contained in Part 2, Division 4 of these regulations, will be administered"--Introd., p. 7. |
---|
692 | 07|2gccst|aPharmaceutical industry |
---|
692 | 07|2gccst|aRetail trade |
---|
692 | 07|2gccst|aGovernment policy |
---|
710 | 1 |aCanada. |bHealth Canada. |
---|
775 | 08|tLigne directrice |w(CaOODSP)9.856867 |
---|
794 | |tGuidance document : |w(CaOODSP)9.866809 |
---|
856 | 40|qPDF|s315 KB|uhttps://publications.gc.ca/collections/collection_2018/sc-hc/H13-9-13-2018-eng.pdf |
---|
856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fees/guidance-document-fees-right-sell-drugs.html |
---|